Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Murugesan Vanangamudi"'
Autor:
Anitha Kuttiappan, Santenna Chenchula, Murugesan Vanangamudi, Shvetank Bhatt, Radhika Chikatipalli, P Shaila Bhanu, Nagaraju Bandaru
Publikováno v:
Journal of Ayurveda and Integrative Medicine, Vol 15, Iss 5, Pp 101036- (2024)
Background: Phytochemicals and their derivatives are promising target drugs for various ailments and have served as therapeutic agents for several decades. Using in vivo and in vitro models and molecular docking, this study investigated the pharmacol
Externí odkaz:
https://doaj.org/article/f85d8fb89c6b410abed876eb4e6a9ad6
Strategies in the Design and Development of Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)
Autor:
Murugesan Vanangamudi, Senthilkumar Palaniappan, Muthu Kumaradoss Kathiravan, Vigneshwaran Namasivayam
Publikováno v:
Viruses, Vol 15, Iss 10, p 1992 (2023)
AIDS (acquired immunodeficiency syndrome) is a potentially life-threatening infectious disease caused by human immunodeficiency virus (HIV). To date, thousands of people have lost their lives annually due to HIV infection, and it continues to be a bi
Externí odkaz:
https://doaj.org/article/d05b5627b564403882c113ebd07acc18
Autor:
Bhanwar Kumar Malviya, Karandeep Singh, Pradeep K. Jaiswal, Monika Shukla, Ved Prakash Verma, Murugesan Vanangamudi, Amanpreet Kaur Jassal, Pinki B. Punjabi, Siddharth Sharma
Publikováno v:
ACS Omega, Vol 4, Iss 7, Pp 12146-12155 (2019)
Externí odkaz:
https://doaj.org/article/d4600e57822247289cf84de3a784ee73
Autor:
Dayma, Varsha, Chopra, Jaishri, Sharma, Poonam, Dwivedi, Aparna, Tripathi, Indra P., Bhargava, Amit, Murugesan, Vanangamudi, Goswami, Ajay K., Baroliya, Prabhat K.
Publikováno v:
In Heliyon August 2020 6(8)
Publikováno v:
Current Pharmaceutical Analysis. 18:650-662
Background: Hybrid polymeric materials have been in research focus owing to their outstanding progression in drug targeting. A new Quality by Design approach by RP-HPLC was developed and validated for the estimation of hybrid polymeric nanoparticles
Publikováno v:
Drug Discovery Today. 27:1874-1894
For emerging and re-emerging epidemic infections, researchers face challenges to develop broad-spectrum antivirals as well as reducing development time and costs, and drug resistance. Drug repurposing is a reliable strategy for rapidly discovering po
Autor:
Laxmi K. Chauhan, Jaishri Chopra, Murugesan Vanangamudi, Indra P. Tripathi, Amit Bhargava, Ajay K. Goswami, Prabhat K. Baroliya
Publikováno v:
Molecular Diversity. 27:223-237
Autor:
Murugesan, Vanangamudi, Makwana, Nandini, Suryawanshi, Rahul, Saxena, Reshu, Tripathi, Rajkamal, Paranjape, Ramesh, Kulkarni, Smita, Katti, Seturam B.
Publikováno v:
In Bioorganic & Medicinal Chemistry 15 June 2014 22(12):3159-3170
Publikováno v:
Current Opinion in Pharmacology. 54:179-187
The non-nucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of HIV-1 reverse transcriptase and are classified into generations depending on their discovery and resistance profiles. The NNRTIs are used in combination regimen
Autor:
Murugesan, Vanangamudi, Tiwari, Vinay S., Saxena, Reshu, Tripathi, Rajkamal, Paranjape, Ramesh, Kulkarni, Smita, Makwana, Nandini, Suryawanshi, Rahul, Katti, Seturam B.
Publikováno v:
In Bioorganic & Medicinal Chemistry 15 November 2011 19(22):6919-6926